🇮🇳 Abreva in India

Abreva (DOCOSANOL) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Abreva in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Dermatology approved in India

Frequently asked questions

Is Abreva approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Abreva in India?

Marketing authorisation holder not available in our data.